During the past decade, The Cardiovascular Institute Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Cardiovascular Institute Hospital" #1 sponsor was "Associations for Establishment of Evidence in Interventions" with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Medtronic Vascular" with 1 trials sponsored and "Micell Technologies" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Cardiovascular Institute Hospital" #1 collaborator was "Cardialysis BV" with 1 trials as a collaborator, "ClinLogix. LLC" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "Medtronic Japan Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "The Cardiovascular Institute Hospital" are "Coronary Artery Disease" (6 trials), "Myocardial Ischemia" (2 trials), "Arterial Occlusive Diseases" (1 trials), "Cardiovascular Diseases" (1 trials) and "Coronary (Artery); Disease" (1 trials). Many other conditions were trialed in "The Cardiovascular Institute Hospital" in a lesser frequency.

Most popular intervention types in "The Cardiovascular Institute Hospital" are "Device" (8 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Absorb™ BVS" (1 trials), "Aspirin" (1 trials), "Clopidogrel" (1 trials), "Cypher stent" (1 trials) and "Everolimus Eluting Stent (EES)" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Cardiovascular Institute Hospital" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Cardiovascular Institute Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in The Cardiovascular Institute Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Cardiovascular Institute Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".